Abstract
Aim
Familial Mediterranean fever (FMF) is the most common inherited autoinflammatory disease in the world. There are known triggers to initiate an FMF attack, yet potential effects of intrauterine devices (IUD) in women of reproductive age have not been evaluated before.
Method
Consecutive female patients with FMF who ever used IUD over the age of 18 were enrolled. Female patients with FMF were sub grouped according to the type of IUD they use. FMF attack frequency, severity, duration, presence of dysmenorrhea, severity of dysmenorrhea, having attacks during menstruation before and after IUD use were questioned. Demographic and clinical data were collected from hospital database.
Results
When all patients with IUD use were evaluated, it was found that the frequency of attacks increased after IUD insertion at 3rd and 12th months (median [min–max] attack frequency at 3rd month, 1 (0–3) vs 1 (0–6), p = 0.002, median [min–max] attack frequency at 12th month, 2 (0–12) vs 3.5 (0–18), p = 0.028). Attack severity measured by VAS pain was also significantly increased. Attack duration and menstrual pain was similar before and after IUD use. Attack frequency at 3rd and 12th months, attack severity and menstrual pain was all increased significantly in Cu-IUD users, whereas none of these parameters deteriorated in LNG-IUD group.
Conclusion
IUD use, especially Cu-IUD, may increase the frequency and severity of attacks in female patients with FMF. Clinicians may benefit from considering LGN-IUD if IUDs are preferred as contraception in women of childbearing age with FMF.
Similar content being viewed by others
Data availability
Data are available from the authors upon request.
References
Tufan A, Lachmann HJ (2020) Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci. 50(Si-2):1591–1610
Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I (2019) The pyrin inflammasome in health and disease. Front Immunol 10:1745
Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43(2):227–253
Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S (2020) The use of interleukine-1 inhibitors in familial Mediterranean fever patients: a narrative review. Front Immunol 11:971
Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A (2006) The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 33(6):1089–1092
Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G et al (2009) Familial Mediterranean fever: a review for clinical management. Joint Bone Spine 76(3):227–233
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885
Clowse ME (2010) Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol 24(3):373–385
Asher I, Sheiner E, Willner NT, Zeller L, Pariente G (2023) Perinatal outcomes and long-term infectious morbidity of offspring born to mothers with familial Mediterranean fever. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-023-07317-w
Ertekin Pinar S, Demirel G, Yildirim G, Daglar G (2019) Sexual experiences and quality of life in Turkish women using methods of contraception. J Obstet Gynaecol 39(6):782–787
Teal S, Edelman A (2021) Contraception selection, effectiveness, and adverse effects: a review. JAMA 326(24):2507–2518
Andrews B, Quick K, MacLeod E, Edwards K, Rone BK (2023) Cervical bleeding with cervical stabilization during IUD placement: allis clamp versus single-tooth tenaculum, a randomized control trial. Arch Gynecol Obstet 307(4):1015–1019
Makhlouf H, Abou-gabal A, El-hefnawi N, Khalifa A (1988) Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users. Popul Sci 8:19–29
Eissa MK, Sparks RA, Newton JR (1985) Immunoglobulin levels in the serum and cervical mucus of tailed copper IUD users. Contraception 32(1):87–95
Fleetwood L, Landgren BM, Eneroth P (1984) IUD-induced changes in cervical secretion content of albumin, IgG and complement C3c. Contraception 29(5):465–470
Radzey N, Harryparsad R, Meyer B, Chen PL, Gao X, Morrison C et al (2022) Genital inflammatory status and the innate immune response to contraceptive initiation. Am J Reprod Immunol 88(2):e13542
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S et al (2023) Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial. Nat Commun 14(1):499
Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339(8796):785–788
Livneh A, Langevitz P (2000) Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14(3):477–498
Shohat M, Halpern GJ (2011) Familial Mediterranean fever—a review. Genet Med 13(6):487–498
Kurultak I, Kinalp C, Ceri M, Evrenkaya TR (2015) Intrauterine device may trigger typical attacks of familial Mediterranean fever: a case report. Wien Klin Wochenschr 127(1–2):68–70
Casella S (1977) Use of Progestasert in the treatment of function dysmenorrhea. Minerva Ginecol 29(7–8):607–610
Kelekci S, Kelekci KH, Yilmaz B (2012) Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Contraception 86(5):458–463
Guzelant G, Ozguler Y, Esatoglu SN, Karatemiz G, Ozdogan H, Yurdakul S et al (2017) Exacerbation of Behçet’s syndrome and familial Mediterranean fever with menstruation. Clin Exp Rheumatol. 35(Suppl 108(6)):95–99
Acknowledgements
This research received no specific grant from any funding agency.
Funding
There is no funding. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Author information
Authors and Affiliations
Contributions
ÖUB: protocol development, data collection and management, manuscript writing, SCG: protocol development, data analysis, manuscript editing, HB: data analysis, manuscript writing, COU: data analysis, manuscript writing, BA: data collection and management, EKE: data collection and management, YM:data collection and management, İD: data collection and management, KO: data collection and management, RKU: data collection and management, EA: data collection and management, AO: protocol development, manuscript editing, OK: protocol development, manuscript editing, ŞE: protocol development, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest was reported by the author(s).
Ethical approval
The study was approved by the Ankara City Hospital Ethics Committee (number: E1-22-3032) and was performed according to the principles of the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Özdemir Ulusoy, B., Güven, S.C., Babaoğlu, H. et al. Effects of intrauterine device use on attack frequency and severity ın woman of reproductive age with familial Mediterranean fever. Arch Gynecol Obstet 309, 2041–2046 (2024). https://doi.org/10.1007/s00404-024-07413-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-024-07413-5